Press Releases
 
Bioengineered Protein Drugs Market to Become Worth US$ 336.9 Billion by 2025

Bioengineered Protein Drugs Market

, 14 February 2018 -- Bioengineered Protein Drugs Market report categorize the global market by Drug Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Disease Condition (Cancer, Diabetes, Autoimmune Disorder, Infectious Disease, Hematopoiesis, CVD, and Neurodegenerative), End User & Geography

As per a report by Transparency Market Research, the global bioengineered protein drugs market will rise at a 7.4% CAGR during the period between 2017 and 2024 to become worth US$336.9 bn by 2025 from US$177.7 bn in 2016.

Report Overview @ https://www.transparencymarketresearch.com/bioengineered-proteins-drugs-market.html

Protein engineering entails building protein through modification of amino acid. Bio engineered proteins drugs are synthesized through genetic engineering. They are used to treat injury, cancers, and also in organ transplants, among others. They are also referred to as Recombinant Protein drugs and are used for modification of immune reactions, through pathophysiological pathways at multiple levels of cells adhesion and activation.

At the forefront of driving the global bioengineered protein drug market is the increasing prevalence of infectious diseases, diabetes, cancer, etc. “Bioengineered protein drugs have proven to be more effective and have reduced or no side effects when compared with alternative therapies for cancer, diabetes, and other maladies. This has led to more healthcare physicians prescribing these drugs, thereby catalyzing growth in the market,” explains the lead analyst of the TMR report.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8188

In the years ahead too, the global market for bioengineered protein drugs is expected to expand at a good clip owing to increasing drugs in phase III of clinical trials and companies funneling money into research and development of novel bioengineered proteins.

Serving to restrain the market, on the other hand, is the high cost of manufacturing bioengineered protein drug, having shorter shelf lifetime and development of bio similar drugs.

Depending upon the type of product, the global bioengineered protein drugs market can be classified into monoclonal antibodies, vaccines, and therapeutic protein. Of them, the therapeutic protein segment leads with maximum share because of extensive activities in the therapeutic protein engineering and recombinant DNA technology products. However, the vaccines segment is anticipated to expand at a significant CAGR from 2017 to 2025 due to rise in the development of bioengineered prophylactic and/or therapeutics vaccines.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8188

Geographically, the key segments of the global bioengineered protein drugs market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, of them, accounts for a dominant share in the market and going forward too is slated to retain its leading share on the back of rising instances of cancer and emergence of innovative protein therapeutics for treatment of cancer. However, the pace of growth in the North America market will be clipped to a degree on account of loss of patent of most of the blockbuster drugs, namely Rituxan, Humira, Avastin, Remicade, etc. The challenge will be overcome by the launch of new drugs in the upcoming years.

Some of the prominent participants in the global bioengineered protein drugs market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Amgen, Inc., Bayer AG, Merck & Co., Inc., Dr. Reddy’s Laboratories Ltd., Biocon Ltd., Eli Lilly and Company, Sanofi, Fresenius Kabi, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Panacea Biotec, ProBioGen AG, and Reliance Life Sciences Pvt. Ltd.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=8188

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com

# # #


Submitted by hawer on Wednesday, 14 February 2018 at 4:22 PM
Category: Health Care & Medical
 
Related News

Steroid users can now get the latest news and report from the approved online retailer
Saturday, 15 Dec 2018

Promotion Tips for Plastic Surgery treatment
Friday, 14 Dec 2018

Global Pharma Excipients Market to Witness Growth by Top Vendors
Friday, 14 Dec 2018

Global Point-Of-Care Testing (POCT) Market Growing At A CAGR Of 9.4% During 2018 - 2025
Friday, 14 Dec 2018

Global Medical Microbiology Testing Technologies Market Booming with the Major Players
Friday, 14 Dec 2018

Related Events

8th Annual Echo on Marco Island: Case-Based Approach
Monday, 17 Dec 2018

Imaging in Beaver Creek
Monday, 7 Jan 2019

Cardiology Update at Puerto Vallarta: A Focus on Prevention
Monday, 7 Jan 2019

BIOTECH SHOWCASE 2019 - 11th Annual Partnering Conference
Monday, 7 Jan 2019

Mayo Clinic Radiation Oncology: Current Practice and Future Direction
Monday, 7 Jan 2019

Latest News

MusConv.com Wins Global Applause For Seamless YouTube To Spotify Conversions
Sunday, 16 Dec 2018

Dance Jewelry Online – Best Place To Buy Dance Jewelry and Costumes
Sunday, 16 Dec 2018

New sleek, hand-held, cleansing bidet for women AND men is now available for funding at Indiegogo
Sunday, 16 Dec 2018

Know What To Wear While Doing Bharatnatyam
Sunday, 16 Dec 2018

Glowing Beauty Duo – Get Younger Skin in 14 Days
Sunday, 16 Dec 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Monday, 17 December 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 8th Annual Echo on Marco Island: Case-Based Approach
  • Palo Alto Networks: Holiday Happy Hour
  • Palo Alto Networks: A More Secure Everywhere
  • Palo Alto Networks: CYBER TUESDAY – CYBER SECURITY BEST PRACTICES – LEVEL 1
  • Palo Alto Networks: Ultimate Test Drive - UTD Public Cloud: mix of the current AWS UTD and Hack

  • Latest Jobs
    Sorry, there are currently no entries posted here.